abstract |
The present invention relates to compounds of the general formula (1) in which R1, R2, R4, Rg, X, m, n and p are as defined in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and to the use thereof for the manufacture of a medicament having the aforementioned properties. |